ACE and inflammatory bowel disease: Observational studies have reported a reduced risk of prescription ofcorticosteroids, hospital admission and intestinal surgeries in IBD patientsusing angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin IIreceptor blockers (ARBs).144, –146These findings need further confirmation.